Skip to main content
Premium Trial:

Request an Annual Quote

Heiner Dreismann

Nucleix has appointed Heiner Dreismann to the company's board of directors. Currently, he serves on the boards of several public and private healthcare companies. From 1985 to 2006, Dreismann has held several senior positions at the Roche Group, including president and CEO of Roche Molecular Systems, head of global business development at Roche Diagnostics and a member of Roche's global diagnostic executive committee.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.